Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Belli

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|December 16, 2015
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinomaCarmen Belli, Lorenzo Piemonti, Maurizio D'Incalci, et al.
The Oncologist|June 1, 2024
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancersCarmen Belli, Luca Boscolo Bielo, Matteo Repetto, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2011
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)Michele Reni, Stefano Cereda, Alessia Rognone, et al.
JAMA Network Open|September 28, 2020
Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal WomenJacopo Troisi, Antonio Raffone, Antonio Travaglino, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trialMichele Reni, Stefano Cereda, Michele Milella, et al.
Cancer|November 6, 2015
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)Francesco Leone, Donatella Marino, Stefano Cereda, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experienceMatteo Repetto, Edoardo Crimini, Luca Boscolo Bielo, et al.
The Oncologist|September 5, 2023
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National ExperienceEdoardo Crimini, Giulia Tini, Paolo Tarantino, et al.
Cancers|November 27, 2021
Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical TrialsPamela Trillo Aliaga, Dario Trapani, José Luis Sandoval, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II TrialMichele Reni, Erica Dugnani, Stefano Cereda, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|December 16, 2015
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinomaCarmen Belli, Lorenzo Piemonti, Maurizio D'Incalci, et al.
The Oncologist|June 1, 2024
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancersCarmen Belli, Luca Boscolo Bielo, Matteo Repetto, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2011
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)Michele Reni, Stefano Cereda, Alessia Rognone, et al.
JAMA Network Open|September 28, 2020
Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal WomenJacopo Troisi, Antonio Raffone, Antonio Travaglino, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trialMichele Reni, Stefano Cereda, Michele Milella, et al.
Cancer|November 6, 2015
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)Francesco Leone, Donatella Marino, Stefano Cereda, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experienceMatteo Repetto, Edoardo Crimini, Luca Boscolo Bielo, et al.
The Oncologist|September 5, 2023
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National ExperienceEdoardo Crimini, Giulia Tini, Paolo Tarantino, et al.
Cancers|November 27, 2021
Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical TrialsPamela Trillo Aliaga, Dario Trapani, José Luis Sandoval, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II TrialMichele Reni, Erica Dugnani, Stefano Cereda, et al.
Pageof 5